EvaLuation of early CRRT and beta-blocker InTervention in patients with ECMO (ELITE) trial: study protocol for a 2 × 2 partial factorial randomized controlled trial.
Xiaofang WangHong WangXin DuZhiyan WangChenglong LiCraig S AndersonJinying ZhangXiaotong HouChunguang QiuPublished in: Trials (2022)
ClinicalTrials.gov NCT03549923 . Registered on 8 June 2018. World Health Organization International Clinical Trials Registry Platform (WHO ICTEP) network. The Ethics Committee of Beijing Anzhen Hospital Approval ID is 2018013.
Keyphrases
- randomized controlled trial
- clinical trial
- study protocol
- phase ii
- phase iii
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- public health
- air pollution
- open label
- healthcare
- particulate matter
- high throughput
- body composition
- big data
- acute care
- respiratory failure
- adverse drug
- double blind
- drug administration
- emergency department
- global health
- angiotensin converting enzyme
- machine learning
- systematic review
- artificial intelligence